Fever in young infants accounts for a large percentage of ER visits and admissions to children's hospitals. High-risk infants have approximately a 10-percent chance of having a serious bacterial infection, while this percentage is much lower in infants identified as low-risk. These bacterial infections as well as neonatal HSV carry a very high risk of morbidity and mortality.
Despite these facts, there is not a national consensus on how these infants should be evaluated and managed. The resulting variability in practice leads to both the under- and over-treatment of the infant with a fever, in addition to confusion among providers and patients' families.
The goal of the febrile young infant clinical practice guideline committee was to develop an evidence-based pathway that highlights the most appropriate use of laboratory testing, antibiotics, and antivirals, allowing us to provide the highest quality, most cost-effective care.
Febrile young infant guidelines team
- Contact: Whitney Browning, Hospital Medicine
- Jim Gay, General Pediatrics
- Melissa Gervase, Pharmacy
- Laurie Lawrence, Emergency Medicine
- Carrie Lind, Hospital Medicine
- Matt Locklair, Emergency Medicine
- Lauren McClain, Resident representative
- Sarah Parker, Hospital Medicine
- Aida Yared, General Pediatrics